Navigation Links
Kendle to Share Insights at Drug Information Association 45th Annual Meeting
Date:6/17/2009

CINCINNATI, June 17 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that several of its executives will present on important industry issues at the Drug Information Association (DIA) 45th Annual Meeting June 21-25, 2009, in San Diego, Calif. Kendle experts will address key topics in clinical development, including regulatory issues in portfolio management, pregnancy registries and risk management, and patient recruitment and retention for pregnancy registries.

Kendle Speakers

    Wednesday, June 24, 3:30-5 p.m., Room 14B
    Managing Development Portfolios in a Safety-Heightened Environment
    William K. Sietsema, PhD
    Vice President, U.S. Regulatory Consulting and Submissions

    Thursday, June 25, 8:30-10 a.m.
    Pregnancy Registries: Perspectives on a Unique Risk Management Tool
    Deborah Covington, DrPH, MS, Senior Director, Late Phase
    Laura F. McKain, MD, Medical Director, Registries and Epidemiology, Late
     Phase

    Poster Presentation
    Pregnancy Exposure Registries: Enhancing Recruitment and Retention
    Deborah Covington, DrPH, MS
    Senior Director, Late Phase

Kendle at Booth #439

Kendle experts will be available for on-site meetings and to discuss the Company's model for consistent quality execution of Phase I-IV clinical development programs and best practices in the development of strategic customer relationships.

In addition to Phase I-IV clinical development capabilities, the Kendle display also will highlight the Company's continued and recent success in delivering consistent quality and building effective site relationships as validated by independent third-party quantitative research. Kendle recently was named the highest-rated top-five CRO in the 2009 CenterWatch Survey of U.S. Investigative Sites. The Company is the only CRO to have been ranked consistently among the top two providers in the 2009, 2008 and 2007 CenterWatch surveys of U.S. and European investigative sites. In addition, according to the "2009 CRO Quality Benchmarking Report" published by Industry Standard Research (ISR), "Kendle delivers the most consistent quality services" as measured by the "Service Variability Index" (SVI), a measurement of consistency, which researchers at ISR identified as the most significant indicator of quality. Kendle's industry-best score was 12.2 (lower score = less variability, and closer to ideal distribution), while the industry average was 25.1. Kendle rated highest among CROs in the areas of CRA Quality, Consistent Quality Delivery, Meeting Project Timelines and Efficient Site Start-up.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO)


'/>"/>
SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kendle to Present at Upcoming Jefferies and Wachovia Securities Conferences
2. Kendle Announces First Quarter 2009 Earnings Conference Call and Webcast
3. Kendle Expands Asia/Pacific Operations with Opening of Additional Office in India
4. Kendle Revises Full Year 2008 Guidance
5. Kendle to Present at 27th Annual J.P. Morgan Healthcare Conference
6. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
7. Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008
8. Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
9. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
10. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
11. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, ... guideline updates for the primary prevention of cardiovascular diseases during the 15th ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
Breaking Medicine Technology: